Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

Phase I Study of Weekly Anti-Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) Monoclonal Antibody IMC-1121B in Patients with Advanced Solid Tumors Who Have Not Responded to Standard Therapy
Ramucirumab
I4T-IE-JVBM
NCT00793975
Advanced Solid Tumors
Phase 1
 
PK and PD data are not included and this data will not be made available.
February 2017

Powered by ideaPoint, Inc.